In our study, we found that fra-1 expression, evaluated by immunohistochemistry, western blot and semiquantitative and quantitative RT-PCR, started to become detectable in fibroadenomas and hyperplastic stage and strongly detectable in carcinoma samples. This evidence concerns the gene FOSL1 and Fibroadenoma.